575 related articles for article (PubMed ID: 7628694)
1. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
[TBL] [Abstract][Full Text] [Related]
2. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
3. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
Van Antwerp DJ; Verma IM
Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633
[TBL] [Abstract][Full Text] [Related]
4. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
[TBL] [Abstract][Full Text] [Related]
5. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
Sun SC; Maggirwar SB; Harhaj E
J Biol Chem; 1995 Aug; 270(31):18347-51. PubMed ID: 7629157
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
Li CC; Dai RM; Longo DL
Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
[TBL] [Abstract][Full Text] [Related]
8. A novel in vitro assay for deubiquitination of I kappa B alpha.
Strayhorn WD; Wadzinski BE
Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
[TBL] [Abstract][Full Text] [Related]
9. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
Traenckner EB; Baeuerle PA
J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651
[TBL] [Abstract][Full Text] [Related]
10. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer DC; Brockman JA; Chen Z; Maniatis T; Ballard DW
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11259-63. PubMed ID: 7479976
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.
DiDonato JA; Mercurio F; Karin M
Mol Cell Biol; 1995 Mar; 15(3):1302-11. PubMed ID: 7862124
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y
EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830
[TBL] [Abstract][Full Text] [Related]
15. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
Sharipo A; Imreh M; Leonchiks A; Imreh S; Masucci MG
Nat Med; 1998 Aug; 4(8):939-44. PubMed ID: 9701247
[TBL] [Abstract][Full Text] [Related]
16. Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.
Renard P; Percherancier Y; Kroll M; Thomas D; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
J Biol Chem; 2000 May; 275(20):15193-9. PubMed ID: 10809754
[TBL] [Abstract][Full Text] [Related]
17. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
18. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
19. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
Desterro JM; Rodriguez MS; Hay RT
Mol Cell; 1998 Aug; 2(2):233-9. PubMed ID: 9734360
[TBL] [Abstract][Full Text] [Related]
20. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
